This study seeks to understand the biological mechanisms driving the symptomatology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using metabolomic and lipidomic high-throughput analysis and high-frequency blood sampling over a 6.5 to 7.5 hour period conducted at two separate sites (Melbourne and Uppsala).
Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for ME/CFS, by Jonas Bergquist, MD, PhD, Uppsala Collaboration
From the desk of Jonas Bergquist, MD, PhD Uppsala University OMF funded paper published in Frontiers of Medicine! Exploring new therapeutic avenues for ME/CFS On behalf of my team at the ME/CFS Collaborative Research Center at Uppsala University, I am pleased to share that we have published an overview of treatment trials for patients in […]
In 2020, OMF secured a $1 million grant to launch the first year of an international, multi-year study across the five OMF funded Collaborative Research Centers (CRC). The aim of this study is to examine Post-COVID Syndrome transitioning to ME/CFS. We are actively working to raise an additional $2 million for years two and three of the study. I am pleased to share with you an update on the first phase of this groundbreaking — and urgently needed — research project:
From the Desk of Jonas Bergquist, MD, PhD Uppsala University Open Medicine Foundation (OMF) is pleased to share the published results of an exciting fully-funded study conducted under the direction of Jonas Bergquist, MD, PhD, Director of the ME/CFS Collaborative Research Center at Uppsala University. This study was designed to validate the increase of autoantibodies observed […]